Cheniere Energy vs State Street SPDR S&P Biotech ETF — how do they compare? Cheniere Energy trades at $277.7 (market cap $57.39B), while State Street SPDR S&P Biotech ETF trades at $153.85 (market cap $10.11B). The key difference: Cheniere Energy is far larger — about 5.7× State Street SPDR S&P Biotech ETF's market cap, and Cheniere Energy pays a 0.8% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cheniere Energy for 10 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| LNG | XBI | |
|---|---|---|
Market Cap | $57.39B | $10.11B |
Volume | 1,215,835 | 12,903,266 |
Sector | Energy | Broad Market / Factor |
52-Week High | $296.91 | $169.55 |
52-Week Low | $188.83 | $104.99 |
Typical Hold Time | 10 Days | 38 Days |
Enterprise Value | $82.85B | — |
Dividend Yield | 0.8% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.
Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Cheniere Energy produces, liquefies, and exports natural gas as liquefied natural gas, or LNG. It operates large-scale LNG infrastructure along the U.S. Gulf Coast.
Read more on LNG →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →